How to beat the virus with early treatment

July 22, 2021- by Steven E. Greer, MD

I woke up yesterday with a slight malaise and I sneezed once. I knew I had come down with a virus of some sort. It was very mild and in the early stages, but I got ahead of it by taking hydroxychloroquine[1], ivermectin[2],[3], aspirin, Vitamin D, and Tamiflu (oseltamivir).

I skipped the pointless testing step for several reasons. The therapy would not have changed regardless of the results. The nasal-swab PCR test not only delays therapy by days (it is crucial to treat early), but it is also infamously unreliable to the point of being dangerous rather than helpful (i.e., false-positives up to 95%). In addition, the point-of-care antibody tests are not sensitive enough and result in false-negatives (for the best test to determine your COVID status, go to NYU Langone and get the blood-drawn panel of antibody assays I helped developed, which I humbly call The Greer Protocol).

Right now, fewer than 24-hours later, I believe I have completely recovered. Whatever the virus was, whether it was a normal common cold coronavirus, the man-made (i.e., gain-of-function in Fauci’s labs) SARS-CoV-2 Wuhan coronavirus, another common cold virus called rhinovirus, or seasonal influenza, I beat the heck out of it.

To be clear, the drugs might have not been the reason for me recovering. I easily could have defeated this virus with my own immune system. We have protection against most viruses from past exposures. However, due to the “delta variant” news, I did not take chances given that the cost and side-effects of the therapies were low. The risk-benefit analysis favors early treatment.

These same early-treatment results (assuming the drugs were the cause in my case) are relevant to almost everyone (see Op-Ed from a patient I treated at Duke University). The COVID virus can be easily treated by low-cost generic drugs available at any pharmacy. My entire pharmacy bill was $100, and that was mostly due to the Tamiflu.

Amid this politicization of the virus and everyone hyping vaccines, it has been completely ignored (by design) that all forms of the man-made coronavirus can be treated. This is not a death sentence. It is an easily treated disease.

I believe this will become known years from now as an atrocity committed by MDs in white coats. The doctors participating in this cover-up should be prosecuted ala the Nuremberg trials after WW2. Already in India, a doctor equivalent to their Tony Fauci (i.e., a political hack) covered up the benefits of these early treatment drugs as a pandering gesture to the W.H.O. She will likely be prosecuted and sentenced to death.

Anyone feeling sick should feel free give me a call if their doctors do not want to prescribe these drugs.

Update August 31, 2022- The CDC added ivermectin to the list of drugs to treat COVID. The CDC page dates this as an April listing, but few seemed to have spotted this. By adding it to this CDC page for other drugs to treat COVID is a big deal.

First, ivermectin is now on a page with other “antivirals”. Simply admitting that is a milestone. Then, the CDC admits that the drug is “being evaluated”. The propagandists have wanted everyone to think this was drug to kill tapeworms in horses and had no antiviral activity.

It is too late now. The serious diseases is behind us. What a crime against humanity.

[1] Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update (see table 2 for a summary of the studies https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959684/ )

[2] Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 https://journals.lww.com/americantherapeutics/fulltext/2021/06000/review_of_the_emerging_evidence_demonstrating_the.4.aspx

[3] Oxford University explores anti-parasitic drug ivermectin as COVID-19 treatment https://www.reuters.com/world/uk/oxford-university-explores-anti-parasitic-drug-ivermectin-covid-19-treatment-2021-06-22/?taid=60d2a4dfe21cb900013b7678

 

 

This entry was posted in - Biotech, - Generics, - Opinion, - Pharma, - Policy, Duke, Emergency medicine, Geriatrics, Infectious disease, Internal Medicine, Pediatrics, Primary care medicine, Pulmonology. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *